Home » Veterinary Biologics Market

Veterinary Biologics Market By Product (Vaccines, Diagnostic Kits, Nutritional and Hormonal Supplement, Allergenic Extract and Others), By Type (Production Animal and Companion Animal) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 11763 | Report Format : PDF

Market Insights:

The veterinary biologics market is expected to grow at a compound annual growth rate (CAGR) of 6.0% between 2018 and 2026, from US$ 17,704.7 million in 2017 to US$ 29,706.9 million by 2026. Veterinary biologics are medicinal products obtained from living organisms and biological processes. They are employed in veterinary health science to diagnose, prevent, and treat animal disease through immune modulation. According to the United States Department of Agriculture (USDA), over the span of 70 years, there has been significant growth in the veterinary biologics market, wherein today approximately 2000 licensed biological products are employed to treat 200 different types of disease in 35 animal species.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Synopsis

The vaccine market is growing due to the increasing prevalence of zoonotic diseases and technological advancements in vaccine production via recombinant DNA technology.

Vaccines are currently leading the product segment for the veterinary biologics market. The major factors contributing to its culminating growth are the rising prevalence of zoonotic disease and technological innovation in veterinary vaccine production employing recombinant DNA technology. Molecular diagnostic kits hold the second-largest market in the products segment on account of the increasing prevalence of contagious diseases in poultry, bovine, and porcine animal species. Nutritional and hormonal supplements will be the fastest-growing market on account of increasing demand in the dairy and meat industries and the growing importance of probiotics to improve the quality of animal feed products.

Proactive government policies focus on long-term sustainable development and improving livestock health to drive the production animal market’s growth.

Currently, production animals reign in the animal type segment pertaining to the veterinary biologics market. Proactive government policies throughout the globe focus on long-term sustainable growth by ensuring total food security and improving livestock healthcare. According to the research findings of the Food and Agriculture Organization (FAO), animal-based food products account for one-third of human protein consumption. The dairy industry’s explosive growth propels the animal production market even further. Companion animals will be the fastest-growing animal type segment in the near future due to significant growth in pet adoption and stringent government norms for mandatory vaccination of pet animals.

The existence of a highly developed agro-based industry and rampant growth in the animal husbandry department drive market growth in North America.

In the present scenario, North America accounts for 40% of the global market share in the veterinary biologics market. The key factors responsible for the dominance of North America are the presence of a highly developed agro-based industry and rapid growth in the animal husbandry department. Rising public animal health awareness and significant growth in pet adoption further fortify the veterinary biologics market’s growth in North America. Europe represents 31% of the market and is the second largest regional segment for the veterinary biologics market.

Increasing growth in the dairy and meat industries and stringent regulatory norms imposed by healthcare agencies for the compulsory vaccination of animals propel the market’s growth in the European region. Asia Pacific holds a 17% market share and will be the fastest-growing market during the forecast period from 2018 to 2026. Rising zoonotic disease prevalence and proactive government policies to financially support veterinary departments consolidate the Asia Pacific veterinary biologics market growth. Latin America, the Middle East, and Africa serve as potential markets for major players to promote business expansion and capture the untapped market in rural areas.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by product, type, and geography.

Biopharmaceutical companies actively participating in the veterinary biologics market are Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Evonik Industries AG, Heska Corporation, Intervet, Inc., INDICAL Bioscience, IDEXX Laboratories, Inc., Virbac, Inc., VCA, Inc., and Zoetis.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key questions are answered in this report.

  • Who are the major biopharmaceutical companies actively participating in the veterinary biologics market?
  • How is the market assessment performed, and what are the latest market trends prevalent in the veterinary biologics market?
  • What are veterinary biologics, and how do they impact animal health?
  • What will be the market size and CAGR for the veterinary vaccines market during the forecast period of 2018 to 2026?
  • What factors are responsible for the dominance of companion animal market growth?
  • What will be the performance of the Asia-Pacific region in the near future?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global VB Market Portraiture
2.2. Global VB Market, by Product, 2017 (US$ Mn)
2.3. Global VB Market, by Type, 2017 (US$ Mn)
2.4. Global VB Market, by Geography, 2017 (US$ Mn)

Chapter 3. Veterinary Biologics (VB) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global VB Market, by Key Players, 2017

Chapter 4. Global Veterinary Biologics (VB) Market, by Product
4.1. Overview
4.2. Vaccines
4.3. Diagnostic Kits
4.4. Nutritional and Hormonal Supplement
4.5. Allergenic Extract
4.6. Others

Chapter 5. Global Veterinary Biologics (VB) Market, by Type
5.1. Overview
5.2. Production Animal
5.3. Companion Animal

Chapter 6. Global Veterinary Biologics (VB) Market, by Geography
6.1. Overview
6.2. North America VB Market Analysis, 2016 – 2026
6.2.1. North America VB Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America VB Market, by Type, 2016 – 2026 (US$ Mn)
6.2.3. North America VB Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe VB Market Analysis, 2016 – 2026
6.3.1. Europe VB Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe VB Market, by Type, 2016 – 2026 (US$ Mn)
6.3.3. Europe VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific VB Market Analysis, 2016 – 2026
6.4.1. Asia Pacific VB Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific VB Market, by Type, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America VB Market Analysis, 2016 – 2026
6.5.1. Latin America VB Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America VB Market, by Type, 2016 – 2026 (US$ Mn)
6.5.3. Latin America VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa VB Market Analysis, 2016 – 2026
6.6.1. MEA VB Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA VB Market, by Type, 2016 – 2026 (US$ Mn)
6.6.3. MEA VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Boehringer Ingelheim Animal Health GmbH
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Ceva Sante Animale
7.3. Evonik Industries AG
7.4. Heska Corporation
7.5. Intetvet, Inc.
7.6. INDICAL Bioscience
7.7. IDEXX Laboratories, Inc.
7.8. Virbac, Inc.
7.9. VCA, Inc.
7.10. Zoetis

List of Figures

FIG. 1 Veterinary Biologics (VB) Market: Research Methodology
FIG. 2 VB Market Segmentation
FIG. 3 Global VB Market, by Product, 2017 (US$ Mn)
FIG. 4 Global VB Market, by Type, 2017 (US$ Mn)
FIG. 5 Global VB Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global VB Market, by Key Players, 2017
FIG. 8 Global Vaccines Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 9 Global Diagnostic Kits Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nutritional and Hormonal Supplements Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 11 Global Allergenic Extracts Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 12 Global Other Products Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 13 Global Production Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 14 Global Companion Animals Market for Veterinary Biologics, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. VB Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada VB Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. VB Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany VB Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe VB Market, 2016 – 2026 (US$ Mn)
FIG. 20 China VB Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan VB Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific VB Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil VB Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico VB Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America VB Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC VB Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA VB Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Veterinary Biologics (VB) Market Portraiture
TABLE 2 Global VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global VB Market , by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global VB Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 7 North America VB Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 10 Europe VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa VB Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa VB Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa VB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Boehringer Ingelheim Animal Health GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Ceva Sante Animale: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Evonik Industries AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Heska Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Intervet, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 INDICAL Bioscience.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 IDEXX Laboratories, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Virbac, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 VCA, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Zoetis: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions:

What is the size of Veterinary Biologics Market?

The market for Veterinary Biologics Market is expected to reach US$ 29,706.9 Mn by 2026.

What is the Veterinary Biologics Market CAGR?

The Veterinary Biologics Market is expected to see significant CAGR growth over the coming years, at 6.0%.

What is the Forecast period considered for Veterinary Biologics Market?

The report is forecasted from 2018-2026.

What is the base year considered for Veterinary Biologics Market?

The base year of this report is 2017.

Who are the major players in this market?

Boehringer Ingelheim Animal Health GmbH, Ceva Sante Animale, Evonik Industries AG, Heska Corporation, Intervet, Inc., INDICAL Bioscience, IDEXX Laboratories, Inc., Virbac, Inc., VCA, Inc are some of the major players in the global market.

Eosinophilic Pneumonia Treatment Market

Published:
Report ID: 5486

Myelodysplastic Syndrome Market

Published:
Report ID: 32821

US Retail Pharmacy Market

Published:
Report ID: 32801

Basal Cell Carcinoma (BCC) Treatment Market

Published:
Report ID: 32698

Paroxysmal Nocturnal Hemoglobinuria Market

Published:
Report ID: 8654

Reversible Airway Diseases Treatment Market

Published:
Report ID: 32531

Pediatric Clinical Trials Market

Published:
Report ID: 32404

Pharmacovigilance Market

Published:
Report ID: 9503

France Retail Pharmacy Market

Published:
Report ID: 31153

Europe Pharma R&D Outsourcing Market

Published:
Report ID: 31143

U.S. Pharma R&D Outsourcing Market

Published:
Report ID: 30984

Pharma R&D Outsourcing Market

Published:
Report ID: 18993

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


support

24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN